Design of a first-in-human multicenter open-label study of ZW171, a mesothelin x CD3 targeting bispecific T-cell engager, in participants with advanced solid tumors: ZWI-ZW171-101.

Authors: Melissa Lynne Johnson, John Turner Hamm, Fiona Thistlethwaite, Myung-Ju Ahn, Erin L. Schenk, Jason J. Luke, Diana L. Hanna, Anna Rachel Minchom, Byoung Chul Cho, Dong-Wan Kim, Rebecca Kristeleit, Dmitriy Zamarin, Catherine Davidson, Joseph Woolery, Pranshul Chauhan, Martin Wermke

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3160

Source: Full article

---

Abstract

TPS3160